FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma

Article Link: FDA Approves Aliqopa (copanlisib) for Adults with Relapsed Follicular Lymphoma



Source: FDA New Drug Approvals